Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report P Malfertheiner, F Megraud, CA O'Morain, J Atherton, ATR Axon, ... Gut 61 (5), 646-664, 2012 | 4197 | 2012 |
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report malfertheiner Gut 61 (5), 646-664, 2012 | 4197 | 2012 |
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report P Malfertheiner, F Megraud, C O’Morain, F Bazzoli, E El-Omar, D Graham, ... Gut 56 (6), 772-781, 2007 | 3575 | 2007 |
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report P Malfertheiner gut 56 (6), 772-781, 2007 | 3575 | 2007 |
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study … M Dinis-Ribeiro, M Areia, AC De Vries, R Marcos-Pinto, ... Endoscopy 44 (01), 74-94, 2012 | 1001 | 2012 |
Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma C Figueiredo, JC Machado, P Pharoah, R Seruca, S Sousa, R Carvalho, ... Journal of the National Cancer Institute 94 (22), 1680-1687, 2002 | 817 | 2002 |
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma JC Machado, C Figueiredo, P Canedo, P Pharoah, R Carvalho, S Nabais, ... Gastroenterology 125 (2), 364-371, 2003 | 640 | 2003 |
Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota RM Ferreira, J Pereira-Marques, I Pinto-Ribeiro, JL Costa, F Carneiro, ... Gut 67 (2), 226-236, 2018 | 563 | 2018 |
Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma JC Machado, P Pharoah, S Sousa, R Carvalho, C Oliveira, C Figueiredo, ... Gastroenterology 121 (4), 823-829, 2001 | 557 | 2001 |
The prevalence of PIK3CA mutations in gastric and colon cancer S Velho, C Oliveira, A Ferreira, AC Ferreira, G Suriano, S Schwartz Jr, ... European journal of cancer 41 (11), 1649-1654, 2005 | 478 | 2005 |
Identification of Germ-Line E-cadherin Mutations in Gastric Cancer Families of European Origin SA Gayther, KL Gorringe, SJ Ramus, D Huntsman, F Roviello, N Grehan, ... Cancer research 58 (18), 4086-4089, 1998 | 452 | 1998 |
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma JC Machado, C Oliveira, R Carvalho, P Soares, G Berx, C Caldas, ... Oncogene 20 (12), 1525-1528, 2001 | 368 | 2001 |
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression C Oliveira, S Velho, C Moutinho, A Ferreira, A Preto, E Domingo, ... Oncogene 26 (1), 158-163, 2007 | 281 | 2007 |
Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses C Persson, P Canedo, JC Machado, EM El-Omar, D Forman American journal of epidemiology 173 (3), 259-270, 2011 | 245 | 2011 |
E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas JC Machado, P Soares, F Carneiro, A Rocha, S Beck, N Blin, G Berx, ... Laboratory investigation 79 (4), 459-466, 1999 | 231 | 1999 |
Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands G Suriano, C Oliveira, P Ferreira, JC Machado, MC Bordin, O De Wever, ... Human molecular genetics 12 (5), 575-582, 2003 | 205 | 2003 |
Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer T Frebourg, C Oliveira, P Hochain, R Karam, S Manouvrier, C Graziadio, ... Journal of medical genetics 43 (2), 138-142, 2006 | 202 | 2006 |
Screening E‐cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred C Oliveira, MC Bordin, N Grehan, D Huntsman, G Suriano, JC Machado, ... Human mutation 19 (5), 510-517, 2002 | 197 | 2002 |
European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients OP Nyssen, D Bordin, B Tepes, Á Pérez-Aisa, D Vaira, M Caldas, ... Gut 70 (1), 40-54, 2021 | 196 | 2021 |
Exosomes and immune response in cancer: friends or foes? FM Barros, F Carneiro, JC Machado, SA Melo Frontiers in immunology 9, 337756, 2018 | 189 | 2018 |